Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Double blind trial of a deuterated form of linoleic acid (RT001) in Friedreich ataxia.
Journal: Journal of neurology
Published: August 29, 2022
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease.
Journal: Science translational medicine
Published: June 08, 2022
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.
Journal: JAMA neurology
Published: June 19, 2018
Strong correlations among four measures of disease progression in Friedreich's ataxia.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: October 05, 2017
Randomized, clinical trial of RT001: Early signals of efficacy in Friedreich's ataxia.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: October 05, 2017
Showing 1-5 of 5
Last Updated: 09/26/2026